Granite Bay Wealth Management, LLC

Position in ABBV — AbbVie Inc.

CIK 1911472 PORTSMOUTH, NH

Position in ABBV

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$737,053

-$2,285,636 QoQ

Shares Held

2,929

-85.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#2,837

of 4,153 holders

Holding Since

Sep 2023

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Granite Bay Wealth Management, LLC holds $16,711,384 across 5 Drug Manufacturers - General names. ABBV ranks #4 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	24,371	$8,825,226
2	LLY	ELI LILLY & Co	4,690	$5,625,326
3	JNJ	Johnson & Johnson	4,696	$1,192,642
4	ABBV	AbbVie Inc. This page	2,929	$737,053
5	GILD	Gilead Sciences, Inc.	2,621	$331,137

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$737,053	2,929	-85.0%	Shares	Sole	2026-08-14
2023-12-31	$3,022,689	19,505	-19.6%	Shares	Sole	2024-01-29
2023-09-30	$3,615,450	24,255	—	Shares	Sole	2023-10-12
No filing history on record for this holder in this stock.